Literature DB >> 7193021

Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.

J M Zwagemakers, V Claassen.   

Abstract

The general pharmacological properties of 1-cyclohexyl-4-[ethyl(p-methoxy-alpha-methylphenethyl)amino]-1-butanone hydrochloride (secoverine hydrochloride), a neurotropic spasmolytic agent with specific antimuscarinic properties, are described. 1. No effects on blood pressure were seen in dogs with doses up to 3 mg/kg .i.v. In hypertensive rats no blood pressure lowering effect was seen after oral doses of 25 and 100 mg/kg. In cats a marginal increase of the blood pressure was observed with i.v. doses up to 3 mg/kg, in pentobarbital-anaesthetized animals. This effect was not present in the chloralose-anaesthetized animal. The sinus carotis occlusion pressor reflex was increased at doses of 0.1 and 0.3 mg/kg but was decreased after an i.v. dose of 3 mg/kg. At a dose of 1 mg/kg i.v. a small decrease in heart contractility was seen. At relative high concentrations, secoverine showed in vitro a non-specific negative inotropic effect on the isolated atrium and rat ventricle strip. 2. No serious effects on the ECG were found in dogs with i.v. doses up to 10 mg/kg. In rabbits at 1 mg/kg i.v. atrioventricular dissociation was seen. In cats irregularly, anaesthetic dependent ventricular ectopics were observed. 3. With 10 mg/kg i.v. doses in rabbits some increase in respiration volume occurred, due to an increase in respiratory frequency and tidal volume. 4. Secoverine had no central depressant effects. In high doses central stimulating effects probably related to the antimuscarinic activity were found. 5. Secoverine did not cause ulceration of the stomach wall of the rat during acute or prolonged oral administration of high doses. A potentiation of ulceration was observed in Shay rats; however, the ulceration in rats caused by acetyl salicylic acid and by reserpine was antagonized by the compound. 6. No effects were seen on blood glucose levels, blood coagulation, platelet aggregation, detoxification mechanisms and diuresis, neither were analgetic or antiinflammatory effects observed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7193021

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  3 in total

1.  The effects of atropine and secoverine on gastric secretion and motility in the mouse isolated stomach.

Authors:  J S Davison; B Greenwood; A Najafi-Farashah; N W Read
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

2.  Action of agonists and antagonists at muscarinic receptors present on ileum and atria in vitro.

Authors:  R U Clague; R M Eglen; A C Strachan; R L Whiting
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

3.  The effect of secoverine hydrochloride on stimulated sigmoid motility: a double-blind, placebo controlled cross-over study in irritable bowel syndrome.

Authors:  M Ehsanullah; D A Lee; T Williams; P Pollard; B Gazzard
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.